UW spinout OctoML increased its funding total to $18.9m after securing series A capital from existing investors Madrona Venture Group and Amplify Partners.

Posco Capital was among the participants as Cytovant, an Asia-focused spinoff from Roivant Sciences, secured $23.5m a year after it was launched.

Ford Motor and KT both contributed to a series A round that increased the total raised by the driver assistance technology developer to $27m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Parkinson's disease therapy developer closed the series A funding less than four months after a Eurofarma-backed seed round.

Based on research at Grousbeck Gene Therapy Center and Massachusetts Eye and Ear, Affinia has raised $60m in a series A round to advance its gene therapies into the clinic.

Lonza participated in the gene therapy developer's series A round alongside Partners Innovation Fund, having also licensed technology to the startup.

Zucara Therapeutics, a diabetes treatment developer exploiting University of Toronto intellectual property, will use the money for phase 1 and 2 trials.

Twaice, a TUM spinout that provides predictive analytics to battery manufacturers, secured the return of UVC Partners to bring its funding haul to $15.7m.